CAP 150 Pill: pink, capsule/oblong, 11mm
The pill with imprint CAP 150 (Pink, Capsule/Oblong, 11mm) has been identified as Capecitabine 150 mg and is used for Colorectal Cancer, Breast Cancer, Metastatic, Pancreatic Cancer, Breast Cancer, and Stomach Cancer. It belongs to the drug class antimetabolites and is not a controlled substance.
Images for CAP 150
Capecitabine
- Imprint
- CAP 150
- Strength
- 150 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shilpa Medicare Limited
- National Drug Code (NDC)
- 63759-3000
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromelloses,
microcrystalline cellulose,
magnesium stearate,
water,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
More about capecitabine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (65)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.